Media Highlights

October 2, 2025

UHealth opens a new AI-focused medical center in North Miami-Dade. What to expect

September 4, 2025

University of Miami adds new paintings to UHealth SoLe Mia Medical Center to honor patient’s journey

Palm Beach Post
August 3, 2025

The Health Frontier: Medical providers expand in Palm Beach County with new clinics, hospitals

More Media Highlights

News

Leidy Lantigua Presenter delivering a talk at a podium during the American Cochlear Implant Alliance CI2026 conference in Chicago, with a projection screen visible on the left and event branding on the lectern.

How Patient Navigation Is Transforming Hearing Loss Care at UHealth

UHealth’s first otolaryngology patient navigator is helping families overcome barriers to care, doubling pediatric cochlear implants.

May. 29 2026 |
Clouds illuminated at sunrise over the Pacific Ocen viewed from the southern cliffs of Bondi Beach, Sydney on 4 March 2023.

New Study Reveals How Extreme Heat Shapes Cancer Care Decisions

A Sylvester Comprehensive Cancer Center study finds extreme heat is influencing how cancer patients access care and make decisions.

May. 29 2026 |
University of Miami Miller School of Medicine interventional radiology faculty and trainees pose in front of GEST 2026 conference signage in New York City.

Miller School Interventional Radiology Demonstrates Global Leadership at GEST 2026

University of Miami Miller School interventional radiology experts showcased research excellence at the global GEST 2026 conference.

May. 29 2026 |
Landscape infographic in University of Miami orange and green illustrating a treatment pathway for relapsed or refractory multiple myeloma, showing that about 70% of patients receiving teclistamab remained progression-free at 18 months compared with about 27% receiving standard therapy, with additional visual elements highlighting longer symptom control, slower disease worsening, and high remission rates.

Teclistamab Improves Outcomes in Relapsed Multiple Myeloma

Teclistamab significantly improves survival and remission in relapsed multiple myeloma, advancing chemotherapy-free immunotherapy care.

May. 29 2026 |

More News

Videos

Social Media